Compound Detail
CHEMBL191
LOSARTAN 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
Basic Information
| ChEMBL ID | CHEMBL191 |
| Name | LOSARTAN |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | PSIFNNKUMBGKDQ-UHFFFAOYSA-N |
| Therapeutic | ✓ Yes |
27
Targets
185
Activities
4
Assay Types
30
PK Parameters
20
Publications
13
Known Names
20
Indications
Molecular Properties
422.9
MW (Da)
4.27
ALogP
6
HBA
2
HBD
92.5
PSA (Ų)
0.44
QED
0
Ro5 Violations
8
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 1995 |
| Availability | Prescription |
| Chirality | Achiral |
Indications
Cardiovascular Diseases Diabetic Nephropathies Essential Hypertension Glioblastoma Glomerulonephritis, IGA Heart Failure Hyperoxaluria, Primary Hypertension Hypertension, Pulmonary Hypertrophy, Left Ventricular Kidney Diseases Marfan Syndrome Non-alcoholic Fatty Liver Disease Non-alcoholic Fatty Liver Disease Proteinuria Renal Insufficiency, Chronic Severe Acute Respiratory Syndrome Severe Acute Respiratory Syndrome Anemia, Sickle Cell Aortic Valve Insufficiency
ATC Classification
C09CA01
losartan
Level 1: CARDIOVASCULAR SYSTEM
Level 2: AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
Activity Summary
IC50 128 meas. best 9.48
Kd 32 meas. best 8.8
Ki 24 meas. best 8.85
EC50 1 meas. best 6.46
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Type-1 angiotensin II receptor CHEMBL227 | IC50 | 9.48 | 7.8744 | 0.3 | 16 |
| HASMC CHEMBL614150 | IC50 | 9.15 | 9.15 | 0.7 | 1 |
| Unchecked CHEMBL612545 | IC50 | 9.09 | 7.8623 | 0.8 | 13 |
| Unchecked CHEMBL612545 | Ki | 8.85 | 8.2017 | 1.4 | 6 |
| Type-1 angiotensin II receptor CHEMBL3948 | Kd | 8.8 | 7.9444 | 1.6 | 9 |
| Oryctolagus cuniculus CHEMBL374 | Kd | 8.8 | 8.425 | 1.6 | 6 |
| Angiotensin II receptor CHEMBL2094256 | Kd | 8.8 | 8.522 | 1.6 | 5 |
| Angiotensin II receptor (AT-1) type-1 CHEMBL2094250 | IC50 | 8.74 | 7.7936 | 1.8 | 14 |
| Angiotensin II receptor (AT-1) type-1 CHEMBL2094250 | Ki | 8.72 | 8.3067 | 1.9 | 3 |
| Type-1 angiotensin II receptor CHEMBL3948 | IC50 | 8.52 | 7.4914 | 3.0 | 14 |
| Type-1 angiotensin II receptor CHEMBL227 | Kd | 8.48 | 8.48 | 3.3 | 1 |
| Type-1 angiotensin II receptor B CHEMBL263 | Ki | 8.44 | 7.7633 | 3.6 | 3 |
| Unchecked CHEMBL612545 | Kd | 8.43 | 8.0083 | 3.7 | 6 |
| Angiotensin II receptor CHEMBL2094112 | IC50 | 8.34 | 7.5678 | 4.6 | 9 |
| Type-1 angiotensin II receptor B CHEMBL263 | IC50 | 8.3 | 7.477 | 5.0 | 10 |
| Type-1 angiotensin II receptor CHEMBL227 | Ki | 8.3 | 7.9925 | 5.0 | 4 |
| Type-2 angiotensin II receptor CHEMBL4607 | Ki | 8.26 | 8.26 | 5.5 | 2 |
| Oryctolagus cuniculus CHEMBL374 | IC50 | 8.21 | 7.81 | 6.1 | 5 |
| Type-1 angiotensin II receptor A CHEMBL329 | IC50 | 8.17 | 7.945 | 6.7 | 2 |
| Angiotensin II receptor CHEMBL2094256 | IC50 | 8.1 | 7.55 | 8.0 | 4 |
| Type-1 angiotensin II receptor A CHEMBL329 | Kd | 8.0 | 7.7 | 10.0 | 2 |
| Type-2 angiotensin II receptor CHEMBL4607 | IC50 | 7.96 | 7.88 | 11.0 | 3 |
| Type-1 angiotensin II receptor A CHEMBL329 | Ki | 7.86 | 7.85 | 13.9 | 2 |
| Type-1 angiotensin II receptor CHEMBL1671613 | IC50 | 7.75 | 7.75 | 18.0 | 2 |
| Angiotensin-converting enzyme CHEMBL1808 | IC50 | 7.72 | 7.72 | 19.0 | 1 |
| Rattus norvegicus CHEMBL376 | IC50 | 7.72 | 7.72 | 19.0 | 1 |
| Angiotensin II receptor CHEMBL2094112 | Ki | 7.5 | 7.5 | 31.6 | 1 |
| Type-1 angiotensin II receptor CHEMBL3374 | IC50 | 7.02 | 6.6854 | 95.0 | 13 |
| Solute carrier organic anion transporter family member 1B1 CHEMBL1697668 | Ki | 6.8 | 6.8 | 160.0 | 1 |
| Solute carrier organic anion transporter family member 1B1 CHEMBL1697668 | IC50 | 6.54 | 6.54 | 288.4 | 1 |
| Type-1 angiotensin II receptor CHEMBL3374 | EC50 | 6.46 | 6.46 | 350.0 | 1 |
| Solute carrier organic anion transporter family member 1B3 CHEMBL1743121 | Ki | 6.05 | 6.05 | 890.0 | 1 |
| Solute carrier organic anion transporter family member 1B3 CHEMBL1743121 | IC50 | 5.94 | 5.94 | 1148.2 | 1 |
| Cytochrome P450 2C9 CHEMBL3397 | IC50 | 5.54 | 5.54 | 2882.0 | 1 |
| Adrenergic receptor alpha-1 CHEMBL1907610 | Kd | 5.46 | 5.46 | 3467.4 | 1 |
| 5-hydroxytryptamine receptor 2C CHEMBL225 | Ki | 5.46 | 5.46 | 3493.0 | 1 |
| Platelet glycoprotein VI CHEMBL3308912 | IC50 | 5.4 | 5.185 | 4000.0 | 4 |
| Type-2 angiotensin II receptor CHEMBL257 | IC50 | 5.13 | 4.52 | 7400.0 | 3 |
| Bile salt export pump CHEMBL6020 | IC50 | 5.07 | 5.07 | 8500.0 | 2 |
| Phosphodiesterase 3 CHEMBL2094125 | IC50 | 4.89 | 4.89 | 13000.0 | 1 |
| Thromboxane A2 receptor CHEMBL2069 | IC50 | 4.7 | 4.7 | 20000.0 | 1 |
| Phosphodiesterase 4 CHEMBL2093863 | IC50 | 4.58 | 4.58 | 26000.0 | 1 |
| Broad substrate specificity ATP-binding cassette transporter ABCG2 CHEMBL5393 | IC50 | 4.46 | 4.46 | 35000.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| AUC | -17707.0 | - | - |
| AUC | -3362.0 | - | - |
| AUC | 12400.0 | ng.hr.mL-1 | Rattus norvegicus |
| AUC | 74800.0 | ng.hr.mL-1 | Rattus norvegicus |
| AUC | 12400.0 | ng.hr.mL-1 | Rattus norvegicus |
| AUC | 74800.0 | ng.hr.mL-1 | Rattus norvegicus |
| AUC | 494.2 | ng.hr.mL-1 | Homo sapiens |
| AUC | 473.0 | ng.hr.mL-1 | Homo sapiens |
| AUC | 366.1 | ng.hr.mL-1 | Homo sapiens |
| AUC | 636.7 | ng.hr.mL-1 | Homo sapiens |
| AUC | 455.2 | ng.hr.mL-1 | Homo sapiens |
| AUC | 518.8 | ng.hr.mL-1 | Homo sapiens |
| AUC | 503.6 | ng.hr.mL-1 | Homo sapiens |
| AUC | 413.2 | ng.hr.mL-1 | Homo sapiens |
| CL | 8.2 | mL.min-1.kg-1 | Homo sapiens |
| CL | 7.3 | mL.min-1.kg-1 | Homo sapiens |
| CL | 8.2 | mL.min-1.kg-1 | Homo sapiens |
| CL | 8.2 | mL.min-1.kg-1 | Homo sapiens |
| CL | 31.67 | mL.min-1.kg-1 | Homo sapiens |
| CL | 26.67 | mL.min-1.kg-1 | Homo sapiens |
| CL | 30.0 | mL.min-1.kg-1 | Homo sapiens |
| CL | 31.67 | mL.min-1.kg-1 | Homo sapiens |
| CL | 21.67 | mL.min-1.kg-1 | Homo sapiens |
| CL | 27.67 | mL.min-1.kg-1 | Homo sapiens |
| CL | 30.33 | mL.min-1.kg-1 | Homo sapiens |
| CL | 28.33 | mL.min-1.kg-1 | Homo sapiens |
| Cmax | 65024.12 | nM | Rattus norvegicus |
| Cmax | 65024.12 | nM | Rattus norvegicus |
| Cmax | 816.23 | nM | Homo sapiens |
| Cmax | 609.1 | nM | Homo sapiens |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| - | 10.6019/CHEMBL3885881 | Rattus norvegicus | 298 |
| - | 10.5281/zenodo.13943903 | ADMET | 89 |
| 31158845 | 10.1038/s41586-019-1291-3 | ADMET | 60 |
| 23118328 | 10.1124/dmd.112.046292 | Homo sapiens | 40 |
| 24200932 | 10.1016/j.bmc.2013.10.017 | Rattus norvegicus | 20 |
| 19863054 | 10.1021/jm9003957 | Rattus norvegicus | 19 |
| 16472241 | 10.2174/1570163043334794 | Hepatotoxicity | 18 |
| 22194678 | 10.1371/journal.pcbi.1002310 | Hepatotoxicity | 14 |
| 22750010 | 10.1016/j.bmc.2012.06.011 | Rattus norvegicus | 12 |
| 15646539 | 10.1016/s0399-8320(04)95062-2 | Unchecked | 11 |
| - | 10.6019/CHEMBL4689842 | HEK-293T | 10 |
| - | 10.6019/CHEMBL4689842 | U2OS | 10 |
| 8064808 | 10.1021/jm00043a020 | Rattus norvegicus | 9 |
| 8568823 | 10.1021/jm950450f | Rattus norvegicus | 9 |
| - | 10.6019/CHEMBL4689842 | Fibroblast | 9 |
| 8246227 | 10.1021/jm00075a014 | Rattus norvegicus | 8 |
| 15646539 | 10.1016/s0399-8320(04)95062-2 | NON-PROTEIN TARGET | 8 |
| 20070106 | 10.1021/jm901371v | Homo sapiens | 8 |
| 17064065 | 10.1021/jm0603163 | Rattus norvegicus | 7 |
| 18318468 | 10.1021/jm7011563 | Rattus norvegicus | 7 |
Data from ChEMBL 36 via Core Engine